DEF 14A: Chemours Faces Shareholder Vote Amid Leadership Changes and Internal Review

Chemours is holding its annual shareholder meeting on May 21, 2024, following a period of leadership changes and an internal review.

Summary

• The Chemours Company is holding its 2024 Annual Meeting of Shareholders virtually on May 21, 2024.
• Shareholders will vote on the election of nine director nominees, an advisory vote on executive compensation, and the ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for fiscal year 2024.
• The Board of Directors took decisive actions following an internal review led by the Audit Committee, including leadership changes and adjustments to incentive compensation.
• Denise Dignam was appointed President and Chief Executive Officer on March 22, 2024, after serving as Interim CEO.
• Matt Abbott was appointed Interim Chief Financial Officer, and a comprehensive search for a permanent CFO is underway.
• The Board added two independent directors, Alister Cowan in November 2023 and Pamela Fletcher in February 2024.
• A new standing committee for environmental, health, and safety and operational performance topics was created.
• The Audit Committee's internal review found that certain senior executives delayed payments to vendors and accelerated the collection of receivables in the fourth quarter of 2023 to meet free cash flow targets.
• The Board and Compensation and Leadership Development Committee (CLDC) exercised full negative discretion for the former CEO and former CFO, resulting in no payouts for incentive compensation tied to free cash flow metrics for the performance periods ended December 31, 2023.
• The company is committed to remediating control deficiencies and has engaged external firms to assist in the development and execution of a comprehensive remediation plan.
• The Board is committed to representing the best interests of Chemours shareholders and regularly evaluates its structure and processes.
• The company awarded approximately $5.6 million in grants in 2023 to support STEM skills, safety initiatives, and sustainable environment programs.
• In 2023, 100% of eligible employees completed the Living Integrity Code of Conduct Training.
• The 2023 AIP design was tied to performance against financial and sustainability metrics.
• At the 2023 Annual Meeting, shareholders approved the Say-on-Pay proposal with 96% of the votes cast in support.

Sentiment

Score: 5

Explanation: The document presents a mixed sentiment. While there are positive aspects such as the appointment of a new CEO and commitment to sustainability, the internal review findings and financial performance challenges weigh negatively on the overall sentiment.

Positives

• Appointment of a new CEO with extensive experience in the chemical industry.
• Addition of two independent directors with valuable expertise.
• Creation of a new committee focused on environmental, health, and safety.
• High shareholder approval (96%) of the Say-on-Pay proposal at the 2023 Annual Meeting.
• Commitment to sustainability and progress on Corporate Responsibility Commitment (CRC) goals.
• The company awarded approximately $5.6 million in grants in 2023 to support STEM skills, safety initiatives, and sustainable environment programs.
• In 2023, 100% of eligible employees completed the Living Integrity Code of Conduct Training.
• The company achieved a 30% reduction in Scope 1 and 2 greenhouse gas (GHG) emissions since 2018.
• The company achieved a 53% reduction in total process fluorinated organic chemical (FOC) emissions to air and water since 2018.

Negatives

• Internal review revealed a lack of transparency with the Board by members of senior management.
• Senior executives engaged in working capital timing actions to meet free cash flow targets.
• The Board exercised full negative discretion for the former CEO and CFO, resulting in no incentive payouts for 2023.
• Material weaknesses in internal control over financial reporting were disclosed in the Annual Report on Form 10-K for the year ended December 31, 2023.

Risks

• The company faces the risk of control deficiencies and material weaknesses in internal control over financial reporting.
• There is a risk of potential litigation and regulatory actions related to environmental, health, and safety issues.
• The company faces the risk of potential conflicts of interest and related party transactions.
• The company faces the risk of potential breaches of confidentiality, non-solicitation and non-competition obligations.

Future Outlook

The company is focused on delivering superior long-term shareholder returns and is committed to taking steps necessary to remediate the control deficiencies that constituted the material weaknesses described in the Company's Annual Report on Form 10-K for the year ended December 31, 2023.

Management Comments

• The Board is confident in the future of our business and committed to ensuring our business is run in a manner that will enable Chemours to reach its full potential.
• The Audit Committee and the full Board recognize that the steps taken to date were a step in the right direction, but that there is more to be done.
• Our Board remains committed to representing the best interests of Chemours shareholders.

Industry Context

The document highlights Chemours' commitment to sustainability and its role in the green economy, aligning with broader industry trends towards environmental responsibility and sustainable solutions.

Comparison to Industry Standards

• The document mentions a compensation peer group consisting of companies like Albemarle Corporation, Axalta Coating Systems Ltd., Celanese Corporation, and Eastman Chemical Company.
• Chemours' executive compensation policies and practices demonstrate a commitment to strong governance standards and include features designed to align the interests of executives with the long-term interests of our shareholders, similar to best practices in the industry.
• The company's sustainability efforts, including the reduction of GHG emissions and FOC emissions, are in line with industry standards and commitments to environmental leadership.
• The company's total shareholder return of 26.5% over the last three years is above the median compared to its compensation peer group.

Management Changes

Corporate Governance

Legal Proceedings

• The company agreed in principle to comprehensively resolve all drinking water claims related to PFAS of a defined class of U.S. public water systems, together with Corteva and DuPont.
• The company announced a settlement agreement with the State of Ohio to resolve PFAS-related claims.

Related Party Transactions

• The company has adopted Policies and Procedures for Transactions with Related Persons to assist it in reviewing, approving and ratifying Related Person Transactions and to assist the Company in preparing the disclosures that the rules and regulations of the SEC require to be included in the Company's applicable SEC filings.

Stakeholder Impact

• The company's performance and governance decisions impact shareholders, employees, customers, suppliers, and creditors.
• The company's commitment to sustainability and environmental responsibility affects communities where it operates.
• The company's remediation efforts and legal settlements related to PFAS impact public water systems and affected individuals.

Next Steps

• Shareholders will vote on the election of directors, executive compensation, and the ratification of the independent registered public accounting firm at the Annual Meeting on May 21, 2024.
• The company will continue to implement enhanced procedures and controls and remediate material weaknesses in its internal control over financial reporting.
• The company will continue to engage with shareholders to understand their views on key topics, including the Audit Committee review and the company's remediation plan.

Key Dates

Keywords

Corporate governance, Executive compensation, Board of Directors, Sustainability, Annual meeting, Chemours, Internal review, Risk management, Director nominees, Proxy statement